Cargando…

Drusenoid Pigment Epithelial Detachment: Genetic and Clinical Characteristics

Few studies report drusenoid pigment epithelial detachment (DPED) in Asians. In this multicenter study, we report the clinical and genetic characteristics of 76 patients with DPED, and, for comparison, 861 patients with exudative age-related macular degeneration (AMD) were included. On the initial p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shijo, Taiyo, Sakurada, Yoichi, Tanaka, Koji, Miki, Akiko, Yoneyama, Seigo, Machida, Yumiko, Chubachi, Aya, Wakatsuki, Yu, Sugiyama, Atsushi, Onoe, Hajime, Kikushima, Wataru, Mori, Ryusaburo, Kashiwagi, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071110/ https://www.ncbi.nlm.nih.gov/pubmed/33920794 http://dx.doi.org/10.3390/ijms22084074

Ejemplares similares

Incidence and risk of advanced age-related macular degeneration in eyes with drusenoid pigment epithelial detachment
por: Shijo, Taiyo, et al.
Publicado: (2022)

Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration
por: Shijo, Taiyo, et al.
Publicado: (2020)

Characteristics of intermediate age-related macular degeneration with hyperreflective foci
por: Kikushima, Wataru, et al.
Publicado: (2022)

Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema
por: Kikushima, Wataru, et al.
Publicado: (2021)

Distinct characteristics of central serous chorioretinopathy according to gender
por: Yoneyama, Seigo, et al.
Publicado: (2022)

Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity
por: Kikushima, Wataru, et al.
Publicado: (2021)

Photodynamic Therapy Treatment for Eyes with Drusenoid Pigment Epithelium Detachment
por: Lee, Na Young, et al.
Publicado: (2008)

Pachydrusen in Fellow Eyes Predict Response to Aflibercept Monotherapy in Patients with Polypoidal Choroidal Vasculopathy
por: Fukuda, Yoshiko, et al.
Publicado: (2020)

Correction: Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy
por: Kikushima, Wataru, et al.
Publicado: (2020)

Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy
por: Wataru, Kikushima, et al.
Publicado: (2020)

Cuticular drusen presenting with central serous chorioretinopathy in both eyes: A case report
por: Hosoda, Shuhei, et al.
Publicado: (2022)

ANATOMIC AND FUNCTIONAL IMPROVEMENT OF A DRUSENOID PIGMENT EPITHELIAL DETACHMENT: A CASE REPORT
por: Csaky, Karl G., et al.
Publicado: (2020)

Bilateral multiple serous retinal detachments after treatment with nivolumab: a case report
por: Miyamoto, Reina, et al.
Publicado: (2020)

Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy
por: Kikushima, Wataru, et al.
Publicado: (2017)

Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration
por: Fukuda, Yoshiko, et al.
Publicado: (2019)

Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degeneration
por: Kikushima, Wataru, et al.
Publicado: (2017)

Coats plus syndrome with new observation of drusenoid retinal pigment epithelial detachments in a teenager()
por: Agrawal, Kushal U., et al.
Publicado: (2022)

Genetic factors associated with response to as-needed aflibercept therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Yoneyama, Seigo, et al.
Publicado: (2020)

Associations Between Retinal Pigment Epithelium and Drusen Volume Changes During the Lifecycle of Large Drusenoid Pigment Epithelial Detachments
por: Balaratnasingam, Chandrakumar, et al.
Publicado: (2016)

Characteristics of Grape Shelf Eye Injuries at Vineyards in Japan
por: Kikushima, Wataru, et al.
Publicado: (2022)

Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular Degeneration
por: Sakurada, Yoichi, et al.
Publicado: (2016)

Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration
por: Gallego-Pinazo, Roberto, et al.
Publicado: (2011)

Surgical Treatment for a Full-Thickness Macular Hole That Developed on a Large Drusenoid Pigment Epithelial Detachment
por: Azuma, Kunihiro, et al.
Publicado: (2021)

One-Year Outcome of Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injections for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy
por: Kitagawa, Yorihisa, et al.
Publicado: (2022)

Laser and anti-vascular endothelial growth factor treatment for drusenoid pigment epithelial detachment in age-related macular degeneration
por: Kim, Min Seok, et al.
Publicado: (2020)

Autologous full-thickness RPE-choroid graft to treat high-risk drusenoid pigment epithelial detachment without CNV
por: Sillen, Hedwig, et al.
Publicado: (2020)

Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy
por: Fukuda, Yoshiko, et al.
Publicado: (2021)

A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result
por: Kikushima, Wataru, et al.
Publicado: (2023)

Morphologic Changes in Patient with Drusen and Drusenoid Pigment Epithelial Detachment after Intravitreal Ranibizumab for Choroidal Neovascular Membrane : A Case Report
por: Kim, Sukjin, et al.
Publicado: (2016)

Two-Thirds Dose Photodynamic Therapy for Pachychoroid Neovasculopathy
por: Tanaka, Koji, et al.
Publicado: (2021)

Impact of drusen and drusenoid retinal pigment epithelium elevation size and structure on the integrity of the retinal pigment epithelium layer
por: Schlanitz, Ferdinand, et al.
Publicado: (2019)

Subretinal drusenoid deposits: An update
por: Monge, Manuel, et al.
Publicado: (2022)

Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: A case report
por: Kogure, Chio, et al.
Publicado: (2021)

Macular drusenoid deposits in X-linked retinoschisis
por: Tandon, Manish, et al.
Publicado: (2013)

Central serous chorioretinopathy and heart rate variability analysis with a smartphone application
por: Takeshima, Keigo, et al.
Publicado: (2020)

In Vivo Multimodal Imaging of Drusenoid Lesions in Rhesus Macaques
por: Yiu, Glenn, et al.
Publicado: (2017)

Subretinal drusenoid deposits versus drusen on multicolor imaging
por: Venkatesh, Ramesh, et al.
Publicado: (2020)

Clinical and Multimodal Imaging Features of Subretinal Drusenoid Deposits
por: Kumawat, Devesh, et al.
Publicado: (2021)

Comments on: Subretinal drusenoid deposits versus drusen on multicolor imaging
por: Ayachit, Apoorva, et al.
Publicado: (2021)

Subretinal Drusenoid Deposit Formation: Insights From Turing Patterns
por: Young, Benjamin K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_17a0g2q15pabgtto7hdro0m828